Bedell Frazier Investment Counseling, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Bedell Frazier Investment Counseling, LLC

$418 Million
Q3 2024

A detailed history of Bedell Frazier Investment Counseling, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Bedell Frazier Investment Counseling, LLC holds 4,813 shares of REGN stock, worth $3.44 Million. This represents 1.21% of its overall portfolio holdings.

Number of Shares

4,813

Previous 4,854 0.84%

Holding current value

$3.44 Million

Previous $5.1 Million 0.82%

% of portfolio

1.21%

Previous 1.23%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$1024.09 - $1201.76 $41,987 - $49,272	-41 Reduced 0.84%	4,813 $5.06 Million
Q2 2024 Aug 09, 2024	SELL	$883.2 - $1071.19 $1.73 Million - $2.1 Million	-1,960 Reduced 28.76%	4,854 $5.1 Million
Q1 2024 May 14, 2024	SELL	$902.69 - $993.35 $54,161 - $59,601	-60 Reduced 0.87%	6,814 $6.56 Million
Q4 2023 Feb 13, 2024	SELL	$775.18 - $881.7 $48,836 - $55,547	-63 Reduced 0.91%	6,874 $6.04 Million
Q3 2023 Nov 13, 2023	SELL	$692.45 - $844.37 $2.2 Million - $2.68 Million	-3,176 Reduced 31.41%	6,937 $5.71 Million
Q2 2023 Aug 14, 2023	SELL	$700.03 - $830.35 $312,913 - $371,166	-447 Reduced 4.23%	10,113 $7.27 Million
Q1 2023 May 09, 2023	SELL	$680.49 - $826.97 $139,500 - $169,528	-205 Reduced 1.9%	10,560 $8.68 Million
Q4 2022 Feb 09, 2023	SELL	$705.89 - $766.39 $214,590 - $232,982	-304 Reduced 2.75%	10,765 $7.77 Million
Q3 2022 Nov 09, 2022	SELL	$573.97 - $724.32 $34,438 - $43,459	-60 Reduced 0.54%	11,069 $7.63 Million
Q2 2022 Aug 03, 2022	SELL	$548.35 - $738.84 $43,868 - $59,107	-80 Reduced 0.71%	11,129 $6.58 Million
Q1 2022 May 10, 2022	SELL	$595.12 - $698.43 $73,794 - $86,605	-124 Reduced 1.09%	11,209 $7.83 Million
Q4 2021 Feb 09, 2022	BUY	$543.48 - $670.97 $36,956 - $45,625	68 Added 0.6%	11,333 $7.16 Million
Q3 2021 Nov 09, 2021	SELL	$574.03 - $680.96 $1.68 Million - $1.99 Million	-2,923 Reduced 20.6%	11,265 $6.82 Million
Q2 2021 Aug 10, 2021	BUY	$472.8 - $558.54 $132,384 - $156,391	280 Added 2.01%	14,188 $7.93 Million
Q1 2021 Apr 29, 2021	BUY	$446.73 - $548.2 $2.55 Million - $3.13 Million	5,714 Added 69.73%	13,908 $6.58 Million
Q4 2020 Feb 10, 2021	BUY	$478.3 - $607.98 $1.91 Million - $2.43 Million	3,993 Added 95.05%	8,194 $3.96 Million
Q3 2020 Nov 05, 2020	SELL	$544.75 - $658.21 $47,938 - $57,922	-88 Reduced 2.05%	4,201 $2.35 Million
Q2 2020 Aug 11, 2020	SELL	$493.32 - $643.92 $12,333 - $16,097	-25 Reduced 0.58%	4,289 $2.68 Million
Q1 2020 May 12, 2020	BUY	$336.18 - $494.43 $1.45 Million - $2.13 Million	4,314 New	4,314 $2.11 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.6B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bedell Frazier Investment Counseling, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bedell Frazier Investment Counseling, LLC with notifications on news.

Account

Bedell Frazier Investment Counseling, LLC Regeneron Pharmaceuticals, Inc. Transaction History